Predictors of change in calcium intake in postmenopausal women after osteoporosis screening

Journal of Nutrition

Volumn 137, Issue 8, 2007, Pages 1968-1973

  McLeod, Katherine M ^a   McCann, Susan E ^b   Horvath, Peter J ^a   Wactawski Wende, Jean ^a,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADULT; AGED; ARTICLE; ATTITUDE TO CHANGE; ATTITUDE TO HEALTH; BODY MASS; BONE DENSITY; CALCIUM INTAKE; CAUCASIAN; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OSTEOPENIA; OSTEOPOROSIS; PATIENT DECISION MAKING; POSTMENOPAUSE; QUESTIONNAIRE; SCORING SYSTEM; SCREENING TEST; T SCORE; UNITED STATES;

EID: 34548070743     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.8.1968     Document Type: Article

References (24)

1. A public health approach to promote bone health. Bone health and osteoporosis: a report of the Surgeon General. 2004. United States Department of Health and Human Services. [cited 20 Aug 2005]. Available from: http://www.surgeongeneral.gov/library/bonehealth/chapter_1.html#PartOne
2. America's bone health: The state of osteoporosis and low bone mass in our nation. Washington (DC): National Osteoporosis Foundation, 2004 [cited 20 Apr 2005]. Available from: (http://www.nof.org/advocacy/prevalence/index.htm)
3. Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: Effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group. Bone. 1999;25:613-9.
4. Maricic M, Chen Z. Bone densitometry. Clin Lab Med. 2000;20:469-88.
5. Osteoporosis prevention, diagnosis, and therapy. NIH consensus statement. 2000; ;17(1):1-45.
6. Risk assessment physician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, 2003. [cited 22 Mar 2001]. Available from: http://www.nof.org/physguide/risk_assessment.htm/.
7. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SAA, Black HR, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669-83.
8. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Food and Nutrition Board Institute of Medicine. 1997. Available from: http://www.iom.edu/?id=12704.
9. Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL. Dietary intake of macronutrients, micronutrients, and other dietary constituents: United States 1988-94. Vital Health Stat 11. 2002;245:1-158.
10. Looker AC. Dietary supplement use in women: current status and future direction. J Nutr. 2003;133:1987S-91S.
11. Rubin SM, Cummings SR. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med. 1992;116:990-5.
12. Jamal SA, Ridout R, Chase C, Fielding L, Rubin LA, Hawker GA. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res. 1999;14:2143-49.
13. Marci CD, Viechnicki MB, Greenspan SL. Bone mineral density substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int. 2000;66:113-8.
14. Rohr CI, Clements JM, Sarkar A. Treatment and prevention practices in postmenopausal women after bone mineral density screening at a community-based osteoporosis project. J Am Osteopath Assoc. 2006;106:396-401.
15. Design of the Women's Health Initiative clinical trial and observational study. The women's health initiative study group. Control Clin Trials. 1998;19:61-109.
16. Kanis JA, Melton III LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137-41.
17. Brennan RM, Wactawski-Wende J, Crespo CJ, Dmochowski J. Factors associated with treatment initiation after osteoporosis screening. Am J Epidemiol. 2004;160:475-83.
18. Looker AC, Orwoll ES, Johnston CC, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761-8.
19. Nieves JW, Komar L, Cosman F, Lindsay R. Calcium potentiates the effect of estrogen and calcitonin on bone mass: Review and analysis. Am J Clin Nutr. 1998;67:18-24.
20. Summers KM, Brock TP. Impact of pharmacist-led community bone mineral density screenings. Ann Pharmacother. 2005;39:243-8.
21. Anastasopoulou C, Rude RK. Bone mineral density screening: assessment of influence on prevention and treatment of osteoporosis. Endocr Pract. 2002;8:199-201.
22. Jones G, Scott FS. Low bone mass in premenopausal parous women: identification and the effect of an information and bone density feedback program. J Clin Densitrom. 1999;2:109-15.
23. Cerulli J, Zeolla M. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc. 2004;44:161-7.
24. Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing. 2004;33:45-51.